Peptide ELISA: Limit dilution 1/64000. Western blot: Use at 0.1-0.3 μg/mL. Approx 90 kDa band observed in Human Brain(Amygdala) lysates (Calculated MW of 95.0 kDa according to NP_056275.2). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
0.5 mg/mL
Buffer
Tris-saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freezing and thawing.
Storage
4 °C/-20 °C
Storage Comment
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C.
Target
MYRIP
(Myosin VIIA and Rab Interacting Protein (MYRIP))
SLAC2-C antibody, SLAC2C antibody, A230081N12Rik antibody, Slac2-c antibody, Slac2c antibody, MYRIP antibody, si:dkey-189e1.4 antibody, LOC100156583 antibody, myosin VIIA and Rab interacting protein antibody, MYRIP antibody, Myrip antibody, myrip antibody
Background
A molecular complex composed of Rab27A, MYRIP and myosin VIIa bridges retinal melanosomes to the actin cytoskeleton and thereby mediates the local trafficking of these organelles. The defect of this molecular complex is likely to account for the perinuclear mislocalization of the melanosomes observed in the retinal pigment epithelium cells of myosin VIIa-defective mice.Synonyms: Exophilin-8, Myosin-VIIa- and Rab-interacting protein, Rab effector MyRIP, SLAC2C, SlaC2-c, Slp homolog lacking C2 domains c